1. Market Research
  2. > Healthcare Market Trends
Global Pressure Ulcer Relief Products Industry

Global Pressure Ulcer Relief Products Industry

  • April 2021
  • 521 pages
  • ID: 5112920
  • Format: PDF
  • Global Industry Analysts

Summary

Table of Contents

MARKET IMPACT SURVEY - COVID-19 & LOOMING RECESSION

Timely market intelligence is paramount in these uncertain times!

We launched an impact survey to update this project with timely insights during 2020. Update frequency will depend upon evolving market conditions and executive opinions. Our participants are executives driving strategy, marketing, sales and product management at competitive companies worldwide. All updates during the rest of the year are complimentary to clients!

Abstract:
- A $20 Billion Dollar Hospice Market Growing at 8% CAGR to Create a $6.9 Billion Opportunity for Pressure Ulcer Relief Products
- The global market for Pressure Ulcer Relief Products is projected to reach US$6.9 billion by the year 2027, trailing a CAGR of 5.9% over the analysis period 2020 through 2027. Providing care for chronic wounds is highly prevalent and involves enormous economic costs for the health care system. With the world`s population rapidly aging, the number of long-term care facilities, hospice are growing in parallel. In the United States, the number of hospice care agencies is growing and stands at approximately 5,100 as of the year 2020. Over 65.6% of hospice care agencies are with for-profit ownership. Bed sores also known as decubitus ulcers are a major cause of mortality in bedridden/immobile patients in long-term care facilities. Stage IV decubitus significantly raises the risk of developing life threatening complications. In addition to hospice, pressure sores are also prevalent in intensive care units accounting for 18.8% of all pressure ulcer cases in the country. It is estimated that around 15% of Medicare beneficiaries in the US suffer from a chronic infection or wound on an annual basis. These wounds are most commonly due to high blood pressure, arterial or venous insufficiency, or diabetes, increasing the co morbidity load in patients and making them more vulnerable to death by COVID-19 infection. In addition, chronic wounds significantly enhance the infection risk as well as incidences of hospitalization, representing a significant portion of the healthcare cost for diabetes patients. Chronic wound patients typically receive treatment in all healthcare settings. The most protocol-driven and organized care is generally provided in the hospital outpatient department (HOPD), or the wound center. Chronic wound patients are often treated on a weekly basis at these centers, where apart from care, other parameters such as blood glucose and vital are also measured along with performing triage for other non-wound-related symptoms.
- Amid the rapidly evolving COVID-19 pandemic, acute care facilities and hospitals are under pressure to modify their standard operating procedures to effectively cater to virus infected patients admitted in specially designed isolation wards. The COVID-19 pandemic has been posing significant challenges in delivering care to chronic wound patients in out-patient units. Due to the fact that most wound centers are generally located inside a hospital, certain hospitals have closed down their wound centers due to safety concerns of the patients. In some cases, the centers have been closed because their services have been categorized as non-essential or due to the hospital`s move of limiting the number of outpatients and visitors inside the hospital premises. In certain cases where wound centers are functioning, they face staffing shortages as some healthcare providers have been assigned for pandemic response. It is expected that the impact of COVID-19 pandemic on the wound patients and the overall healthcare system would last for the at least the next 18 months. Individuals with chronic wounds such as diabetic foot ulcers, arterial ulcers, venous ulcers, and pressure ulcers, many of whom suffer from other chronic conditions such as Type II diabetes, peripheral arterial disease, venous insufficiency, hypertension, and chronic kidney disease, among others are at high risk for increased mortality and morbidity in case the access to wound care is discontinued abruptly. The risk of disruptions in the care of chronic wound patients can potentially lead to several adverse outcomes, such as hospitalizations, emergency room visits, and amputations. For keeping wound patients safer within their homes, federal agencies, such as the US Centers for Medicare and Medicaid Services (CMS), are taking steps for promoting medical care delivery to patients at their homes.
- In the post pandemic period, the growth in the market will continue to be driven by the rise in mobility disorders among the aging population as a result of stroke, neurological disorders, and orthopedic conditions. Given the growing healthcare burden associated with treating medical complications related to pressure ulcers and chronic wounds, there is growing emphasis on implementing best practices for ulcer prevention and management. The market is also expected to benefit from the development of topical pharmacological products with platelet-derived growth factors; and the continuous focus shed on researching the use of biophysical agents such as electrical stimulation, electromagnetic agents, pulsed radio frequency energy and phototherapy in the management of ulcers. The emphasis on prevention will drive development of therapeutic mattresses to reduce ulcer incidence. The market will also benefit from growing research and development investments in biological dressings for the treatment of pressure ulcers such as skin substitutes, xenografts, allografts and collagen dressings. Foam dressings with hydrophilic polyurethane foam will grow in demand for the treatment of highly exuding pressure ulcers. With body mass index being predictive of pressure ulcer risk, the growing base of obese population worldwide will support the expansion of addressable market opportunities for pressure ulcer relief products. The lack of reimbursement will additionally drive focus on the prevention of hospital-acquired pressure ulcers (HAPUS). The United States and Europe represent large markets worldwide supported by widespread incidence and prevalence of decubitus ulcers and chronic wounds among the aging baby boomers and innovation in products and new treatment modalities. Asia-Pacific including China will remain a major market led by improving healthcare infrastructure; establishment of dedicated wound healing centers; focus on providing affordable healthcare services; and development of wound healing programs as part of medical tourism packages.

- Select Competitors (Total 117 Featured) -
  • 3M
  • ArjoHuntleigh
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • Essity AB
  • GF Health Products
  • Inc.
  • Hill-Rom Company
  • Inc.
  • Integra LifeSciences
  • Invacare Corp.
  • James Consolidated Inc.
  • Joerns Healthcare
  • Linet spol. s.r.o
  • Mölnlycke Health Care AB
  • Permobil
  • Smith & Nephew plc
  • Span-America Medical Systems
  • Inc.
  • Steigelmeyer Group
  • Stryker Corp.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Medical Engineered Materials Market by Type, Application And Region - Global Forecast to 2025

  • $ 4950
  • April 2021
  • 220 pages

The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare ...

  • World
  • Europe
  • Healthcare
  • Wound Care
  • Industry analysis
  • Health Expenditure
  • Medical Technology Density

Global Electrosurgery Industry $ 4950 April 2021

Global Medical X-Ray Industry $ 5450 April 2021


ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on